Chandarith

Medical illustration explaining erectile dysfunction, including its causes, symptoms, diagnosis, treatment, and prevention.

Erectile Dysfunction: Causes, Symptoms, Diagnosis & Treatment

Introduction

Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection firm enough for satisfactory sexual activity. It is a common medical condition that can affect men of any age, although its prevalence increases with age.

ED is not simply an inevitable consequence of aging. It may be associated with diabetes mellitus, hypertension, cardiovascular disease, obesity, hormonal disorders, psychological stress, and certain medications.

Importantly, erectile dysfunction can be an early warning sign of underlying cardiovascular disease. Recognizing and treating ED may therefore improve sexual health, quality of life, and overall health.

With appropriate assessment and evidence-based treatment, many men can achieve meaningful improvement in erectile function.

1. What Causes Erectile Dysfunction?

A normal erection requires coordination between the brain, nerves, hormones, blood vessels, and penile tissues. Sexual stimulation triggers the release of nitric oxide, which increases cyclic guanosine monophosphate (cGMP). This relaxes smooth muscle in the corpus cavernosum, allowing increased blood flow and penile rigidity.

Erectile dysfunction occurs when one or more parts of this process are impaired.

A. Vascular causes

Vascular disease is one of the most common causes of ED.

Contributing conditions include:

  • Atherosclerosis and endothelial dysfunction.
  • Hypertension.
  • Diabetes mellitus.
  • Dyslipidemia, including elevated LDL cholesterol.
  • Obesity and metabolic syndrome.
  • Smoking and physical inactivity.
  • Peripheral artery disease.

Reduced arterial inflow or impaired veno-occlusion can prevent the penis from achieving or maintaining sufficient rigidity.

B. Diabetes mellitus

Diabetes can cause ED through several mechanisms, including:

  • Endothelial dysfunction and impaired nitric oxide availability.
  • Diabetic autonomic and peripheral neuropathy.
  • Increased atherosclerotic burden.
  • Associated hypogonadism and psychological factors.

Men with diabetes should receive appropriate assessment of erectile symptoms and cardiovascular risk factors.

C. Hormonal causes

Hormonal abnormalities may contribute to erectile problems, particularly when accompanied by reduced sexual desire.

Potential causes include:

  • Hypogonadism or testosterone deficiency.
  • Hyperprolactinemia.
  • Thyroid dysfunction in selected patients.
  • Pituitary or hypothalamic disorders.

Low testosterone is not the cause of every case of ED. Hormonal treatment should be based on symptoms and appropriate laboratory confirmation.

D. Psychological causes

Psychological factors may include:

  • Performance anxiety.
  • Depression or anxiety disorders.
  • Relationship difficulties.
  • Chronic stress.
  • Sexual trauma or negative sexual experiences.

Psychogenic and organic causes can coexist. Sudden onset, situational symptoms, and preserved spontaneous or morning erections may suggest a psychological component, but they do not exclude an underlying physical disorder.

E. Medications and substances

Certain medications may contribute to ED, including some:

  • Antidepressants and antipsychotics.
  • Antihypertensive agents.
  • Opioids.
  • Hormonal therapies and antiandrogens.

Alcohol misuse, tobacco, and recreational drugs may also impair erectile function.

Patients should not stop prescribed medication without consulting their clinician. When appropriate, the clinician can consider alternative treatments or dose adjustments.

2. Risk Factors for Erectile Dysfunction

Important risk factors include:

  • Increasing age.
  • Diabetes mellitus.
  • Hypertension and cardiovascular disease.
  • High LDL cholesterol and hypertriglyceridemia.
  • Obesity and metabolic syndrome.
  • Smoking.
  • Physical inactivity.
  • Chronic kidney disease.
  • Depression, anxiety, and relationship stress.
  • Pelvic surgery, radiotherapy, or trauma.
  • Certain prescription medications.

Having one or more risk factors does not mean ED is inevitable. Many contributing factors are treatable.

3. Symptoms and Clinical Presentation

The main symptom is difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity.

Patients may report:

  • Difficulty obtaining an erection.
  • Loss of erection before or during intercourse.
  • Reduced erection firmness.
  • Inconsistent erectile function.
  • Reduced sexual confidence or intimacy-related distress.

Erectile dysfunction should be distinguished from other sexual health problems, including reduced libido, premature ejaculation, delayed ejaculation, and orgasmic disorders. These conditions may occur together but require separate assessment.

4. How Is Erectile Dysfunction Diagnosed?

Diagnosis usually begins with a medical history, sexual history, physical examination, and selected laboratory investigations.

A. Medical and sexual history

The clinician should assess:

  • Onset, duration, severity, and progression of symptoms.
  • Ability to achieve versus maintain an erection.
  • Morning or spontaneous erections.
  • Sexual desire, ejaculation, and orgasm.
  • Relationship factors and psychological stress.
  • Cardiovascular risk factors and exercise tolerance.
  • Diabetes, hypertension, dyslipidemia, kidney disease, and other comorbidities.
  • Previous pelvic surgery, trauma, or cancer treatment.
  • Current medications, supplements, tobacco, and alcohol use.

Validated questionnaires such as the International Index of Erectile Function (IIEF) or its five-item version, the IIEF-5/SHIM, can help assess severity and monitor treatment response.

B. Physical examination

The examination may include:

  • Blood pressure, pulse, body mass index, and waist circumference.
  • Cardiovascular and peripheral vascular assessment.
  • Examination of the penis for anatomical abnormalities or plaques.
  • Testicular examination when indicated.
  • Assessment for signs of androgen deficiency or other endocrine disorders.

The extent of examination depends on the clinical presentation and suspected cause.

C. Laboratory investigations

Testing should be individualized. Common initial investigations include:

Investigation Clinical purpose
Fasting glucose or HbA1c Detect diabetes or assess glycemic control
Lipid profile Assess dyslipidemia and cardiovascular risk
Early-morning total testosterone Assess possible testosterone deficiency
Renal function Evaluate relevant comorbidity
TSH or prolactin Test when symptoms or findings suggest an endocrine cause

If morning testosterone is low, it should generally be repeated on another morning before diagnosing hypogonadism. Further tests, such as LH, FSH, or prolactin, may be appropriate depending on the findings.

Specialized investigations, including penile Doppler ultrasound, nocturnal penile tumescence testing, or other vascular studies, are not routinely required for every patient. They may be useful in selected complex cases or when results would change management.

5. Erectile Dysfunction and Cardiovascular Disease

ED and cardiovascular disease share many risk factors, including diabetes, hypertension, smoking, dyslipidemia, and endothelial dysfunction.

In some men, erectile symptoms appear before clinically apparent coronary artery disease because penile arteries may become symptomatic from vascular disease before larger coronary arteries.

The 2024 Princeton IV consensus recommends treating predominantly vasculogenic ED as an important cardiovascular risk marker and assessing overall cardiovascular risk. <Cite refs={[“turn417277search1″,”turn417277search0”]}/>

Evaluation may include:

  • Blood pressure measurement.
  • Diabetes and lipid screening.
  • Smoking and lifestyle assessment.
  • Estimation of cardiovascular risk using an appropriate validated tool.
  • Further cardiac assessment when symptoms, risk level, or exercise tolerance warrant it.

Men with chest pain, unexplained shortness of breath, exertional faintness, or unstable cardiovascular disease should undergo appropriate medical evaluation before resuming sexual activity or starting ED treatment.

6. Treatment of Erectile Dysfunction

Treatment should be individualized according to the underlying cause, cardiovascular safety, patient preference, medication interactions, and treatment response.

A. Lifestyle modification

Lifestyle interventions are important for almost all men with ED.

Recommended measures include:

Regular physical activity: Aim for at least 150 minutes of moderate-intensity aerobic activity per week when medically appropriate.

Weight management: Weight reduction in men with overweight or obesity may improve erectile function and metabolic health.

Healthy diet: Favor vegetables, fruit, legumes, whole grains, nuts, fish, and unsaturated fats. A Mediterranean-style dietary pattern is a useful model.

Smoking cessation: Smoking damages vascular function and increases cardiovascular risk.

Limit alcohol: Avoid heavy alcohol consumption.

Control chronic diseases: Optimize diabetes, blood pressure, dyslipidemia, and other relevant conditions.

Improve sleep and mental health: Address sleep problems, stress, depression, anxiety, and relationship difficulties.

Lifestyle treatment can improve erectile function and overall health, although some men will also need medication or other therapies.

B. First-line oral treatment: PDE5 inhibitors

Phosphodiesterase type 5 (PDE5) inhibitors are commonly used as first-line pharmacological treatment when appropriate.

They enhance the nitric oxide–cGMP pathway, promoting smooth-muscle relaxation and penile blood flow during sexual stimulation.

Common options include:

Sildenafil

  • Common starting dose: 50 mg orally as needed.
  • Usual dose range: 25–100 mg.
  • Usually taken approximately 30–60 minutes before sexual activity.
  • A high-fat meal may delay its onset.

Tadalafil

  • Common starting dose: 10 mg orally as needed.
  • Usual as-needed dose range: 5–20 mg.
  • May be taken at least 30 minutes before sexual activity; its effect can last up to approximately 36 hours.
  • A daily regimen, commonly 2.5–5 mg, may suit selected patients who prefer more spontaneous sexual activity or have coexisting lower urinary tract symptoms.

Vardenafil and avanafil are alternative options where available and clinically appropriate.

Doses must be adjusted for tolerability, renal or hepatic impairment, interacting medicines, and local prescribing information. These medicines require sexual stimulation and do not directly increase sexual desire.

Common adverse effects include headache, flushing, nasal congestion, indigestion, and dizziness. Sildenafil and related agents may cause visual disturbances; tadalafil may cause back pain or muscle aches.

Important safety precautions

PDE5 inhibitors must not be combined with nitrate medications, such as nitroglycerin or isosorbide, or with recreational nitrites (“poppers”), because severe hypotension may occur.

They are also contraindicated with riociguat. Caution is required with alpha-blockers, low blood pressure, significant renal or hepatic impairment, and certain CYP3A4-interacting medicines.

Men with unstable cardiovascular disease or symptoms suggesting unsafe exertion require assessment before sexual activity and ED treatment.

If chest pain occurs after taking a PDE5 inhibitor, seek emergency medical care and inform the treating team which medicine was taken and when. Do not self-administer nitrates.

C. Testosterone replacement therapy

Testosterone therapy is not a routine treatment for every man with ED.

It may be considered when the patient has compatible symptoms and repeatedly low morning testosterone concentrations, after evaluation of the cause and potential contraindications.

In men with confirmed testosterone deficiency, treatment may improve libido and other symptoms and may improve erectile function in selected patients. Some men will still require a PDE5 inhibitor.

Testosterone therapy requires monitoring and is not appropriate for men seeking immediate fertility, because it can suppress sperm production. Evaluation should also consider hematocrit, prostate-related risks when appropriate, sleep apnea, and cardiovascular or other relevant comorbidities.

D. Psychosexual counseling

Counseling or cognitive behavioral approaches may be beneficial when performance anxiety, depression, stress, or relationship difficulties contribute to ED.

Psychological support can also be combined with medication in men who have both organic and psychological factors. Partner involvement may be helpful when the patient wishes.

E. Vacuum erection devices

A vacuum erection device draws blood into the penis using negative pressure. A constriction ring helps maintain the erection during sexual activity.

Potential advantages include avoiding systemic medication effects and providing a noninvasive option. Possible disadvantages include bruising, discomfort, penile coolness, or difficulty with device use.

F. Intracavernosal injections and intraurethral therapy

Alprostadil may be administered by intracavernosal injection or, in selected settings, through an intraurethral formulation.

These options may help patients who do not respond to, cannot tolerate, or cannot use oral medications.

Patients require appropriate instruction regarding administration and adverse effects. Prolonged erections and priapism are important risks, and an erection lasting four hours or longer requires emergency assessment.

G. Penile prosthesis surgery

Penile prosthesis implantation may be considered for men with persistent ED who do not respond to or prefer not to use less invasive treatments.

Options include inflatable and malleable devices. Surgery can provide reliable rigidity, but it involves operative risks, including infection and mechanical complications. Counseling should cover the irreversible nature of some treatment choices, expected outcomes, and alternatives.

H. Treatments with limited or uncertain evidence

Low-intensity shockwave therapy may be discussed in selected men, particularly those with mild vasculogenic ED, but the evidence, patient selection, and durability of benefit remain important considerations.

Platelet-rich plasma injections, stem-cell treatments, and other advertised regenerative therapies lack sufficient high-quality evidence for routine use. Patients should be cautious about claims of permanent cures or guaranteed results.

7. What If Oral Medication Does Not Work?

Before declaring a PDE5 inhibitor ineffective, the clinician should check:

  1. Whether the medication and dose are appropriate.
  2. Whether it was taken at the correct time.
  3. Whether sufficient sexual stimulation was present.
  4. Whether a high-fat meal delayed sildenafil absorption.
  5. Whether the patient tried the treatment on several separate occasions as instructed.
  6. Whether underlying diabetes, vascular disease, hormonal problems, or psychological factors need treatment.
  7. Whether drug interactions or adverse effects limit use.

When oral treatment remains ineffective despite appropriate use, consider specialist referral and alternative therapies such as a vacuum erection device, alprostadil, or penile prosthesis.

8. Can Erectile Dysfunction Be Prevented?

Not every case can be prevented, but risk reduction may help maintain erectile and cardiovascular health.

Practical preventive measures include:

  • Maintain a healthy weight.
  • Exercise regularly.
  • Eat a balanced, heart-healthy diet.
  • Avoid tobacco.
  • Limit alcohol and avoid recreational drugs.
  • Monitor blood pressure, blood glucose, and cholesterol.
  • Take prescribed medication as directed.
  • Seek care for persistent sexual symptoms or psychological distress.

Men with diabetes or cardiovascular disease should receive regular follow-up to optimize risk-factor control.

9. When Should You See a Doctor?

Arrange a medical assessment if erectile difficulties are persistent, recurrent, or causing distress. Early assessment may identify treatable metabolic, vascular, hormonal, medication-related, or psychological causes.

Seek urgent medical care for:

  • An erection lasting four hours or longer.
  • Chest pain or severe shortness of breath during sexual activity.
  • Sudden penile injury with pain, swelling, or deformity.
  • New severe neurological symptoms.

Do not buy unregulated sexual-enhancement products from unknown sources. Some contain undeclared prescription drugs or unsafe ingredients.

Frequently Asked Questions (FAQ)

1. Is erectile dysfunction a normal part of aging?

ED becomes more common with age, but it is not an inevitable part of aging. Persistent symptoms should be evaluated because many causes are treatable.

2. Can diabetes cause erectile dysfunction?

Yes. Diabetes can damage blood vessels and nerves and may contribute to hormonal abnormalities. Good diabetes control and treatment of associated cardiovascular risk factors are important.

3. Does erectile dysfunction mean I have heart disease?

Not necessarily. However, ED may be an early marker of vascular disease. A clinician should assess cardiovascular risk, particularly when ED is new or unexplained.

4. Which medicine is best for erectile dysfunction?

Sildenafil and tadalafil are commonly used options. The best choice depends on medical history, contraindications, interactions, desired duration of action, cost, and patient preference.

5. Can sildenafil be taken every day?

Sildenafil is generally used as needed rather than as a standard daily ED regimen. Daily tadalafil is an option for selected patients. A clinician should determine the appropriate regimen.

6. Can erectile dysfunction be cured permanently?

Some cases improve substantially when the underlying cause is treated, such as medication-related problems or lifestyle-related vascular risk. Other cases require ongoing treatment. There is no single permanent cure that works for everyone.

7. Does testosterone treatment improve erections?

It may help men with confirmed testosterone deficiency, especially when reduced libido is present. It is not recommended solely because of ED or a single low testosterone result.

8. Is erectile dysfunction psychological or physical?

It can be either, or both. A thorough assessment helps identify contributing factors and select suitable treatment.

9. Are herbal supplements safe for erectile dysfunction?

Not necessarily. Some products contain undisclosed pharmaceutical ingredients, interact with prescribed medicines, or have uncertain quality and safety. Discuss supplements with a healthcare professional before use.

10. When should I see a urologist?

Referral may be appropriate for complex cases, penile deformity, suspected endocrine or vascular disorders requiring specialist assessment, treatment failure, or consideration of injections or surgery.

Conclusion

Erectile dysfunction is a common and treatable condition that can affect physical health, emotional well-being, and intimate relationships. Its causes include vascular disease, diabetes, hormonal abnormalities, psychological factors, and medication effects.

Evidence-based care begins with a comprehensive assessment and cardiovascular risk evaluation, followed by lifestyle changes and individualized treatment. PDE5 inhibitors are effective for many men, while counseling, vacuum devices, injections, and penile prostheses offer additional options when needed.

Men should seek professional medical advice rather than rely on unregulated products or self-medication. Early evaluation can improve sexual health and may identify important underlying medical conditions.

Medical disclaimer: This article is for educational purposes only and does not replace an individual medical consultation, examination, or prescription. Treatment should be selected by a qualified healthcare professional after assessing contraindications and individual risk factors.

References

  1. European Association of Urology (EAU). EAU Guidelines on Sexual and Reproductive Health, 2026: Management of Erectile Dysfunction. Available at: https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction
  2. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology. 2018;200(3):633–641. doi:10.1016/j.juro.2018.05.004.
  3. Köhler TS, Kloner RA, Rosen RC, et al. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings. 2024;99(9):1500–1517. doi:10.1016/j.mayocp.2024.06.002.
  4. Kloner RA, Burnett AL, Miner M, et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. The Journal of Sexual Medicine. 2024;21(2):90–116. doi:10.1093/jsxmed/qdad163.
  5. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: 2026 Edition. Available at: https://uroweb.org/guidelines/sexual-and-reproductive-health
  6. American Urological Association. Erectile Dysfunction: Guideline and clinical resources. Available at: https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
Scroll to Top